Literature DB >> 29708159

New concepts in the treatment of malignant pleural mesothelioma.

Moshe Lapidot1, Samuel Freyaldenhoven1, Raphael Bueno1.   

Abstract

Entities:  

Year:  2018        PMID： 29708159      PMCID： PMC5906329          DOI： 10.21037/jtd.2018.02.75

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  11 in total

1.  Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.

Authors:  Hedy L Kindler; Theodore G Karrison; David R Gandara; Charles Lu; Lee M Krug; James P Stevenson; Pasi A Jänne; David I Quinn; Marianna N Koczywas; Julie R Brahmer; Kathy S Albain; David A Taber; Samuel G Armato; Nicholas J Vogelzang; Helen X Chen; Walter M Stadler; Everett E Vokes
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

Review 2.  An overview of chemotherapy for mesothelioma.

Authors:  Lee M Krug
Journal:  Hematol Oncol Clin North Am       Date:  2005-12       Impact factor: 3.722

3.  The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass.

Authors:  Valerie Rusch; Elizabeth H Baldini; Raphael Bueno; Marc De Perrot; Raja Flores; Seiki Hasegawa; Walter Klepetko; Lee Krug; Loïc Lang-Lazdunski; Harvey Pass; Walter Weder; David J Sugarbaker
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02-14       Impact factor: 5.209

4.  Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.

Authors:  Raphael Bueno; Eric W Stawiski; Leonard D Goldstein; Steffen Durinck; Assunta De Rienzo; Zora Modrusan; Florian Gnad; Thong T Nguyen; Bijay S Jaiswal; Lucian R Chirieac; Daniele Sciaranghella; Nhien Dao; Corinne E Gustafson; Kiara J Munir; Jason A Hackney; Amitabha Chaudhuri; Ravi Gupta; Joseph Guillory; Karen Toy; Connie Ha; Ying-Jiun Chen; Jeremy Stinson; Subhra Chaudhuri; Na Zhang; Thomas D Wu; David J Sugarbaker; Frederic J de Sauvage; William G Richards; Somasekar Seshagiri
Journal:  Nat Genet       Date:  2016-02-29       Impact factor: 38.330

5.  Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.

Authors:  Gérard Zalcman; Julien Mazieres; Jacques Margery; Laurent Greillier; Clarisse Audigier-Valette; Denis Moro-Sibilot; Olivier Molinier; Romain Corre; Isabelle Monnet; Valérie Gounant; Frédéric Rivière; Henri Janicot; Radj Gervais; Chrystèle Locher; Bernard Milleron; Quan Tran; Marie-Paule Lebitasy; Franck Morin; Christian Creveuil; Jean-Jacques Parienti; Arnaud Scherpereel
Journal:  Lancet       Date:  2015-12-21       Impact factor: 79.321

6.  Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years.

Authors:  Joseph S Friedberg; Charles B Simone; Melissa J Culligan; Andrew R Barsky; Abigail Doucette; Sally McNulty; Stephen M Hahn; Evan Alley; Daniel H Sterman; Eli Glatstein; Keith A Cengel
Journal:  Ann Thorac Surg       Date:  2016-11-05       Impact factor: 4.330

Review 7.  New Concepts in the Treatment of Malignant Pleural Mesothelioma.

Authors:  Ori Wald; David J Sugarbaker
Journal:  Annu Rev Med       Date:  2017-10-13       Impact factor: 13.739

8.  Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival.

Authors:  Jennifer L Beebe-Dimmer; Jon P Fryzek; Cecilia L Yee; Tapashi B Dalvi; David H Garabrant; Ann G Schwartz; Shirish Gadgeel
Journal:  Clin Epidemiol       Date:  2016-10-26       Impact factor: 4.790

Review 9.  Systemic treatments for mesothelioma: standard and novel.

Authors:  Hedy Lee Kindler
Journal:  Curr Treat Options Oncol       Date:  2008-09-03

10.  Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.

Authors:  Loïc Lang-Lazdunski; Andrea Bille; Sophie Papa; Stuart Marshall; Rohit Lal; Carlotta Galeone; David Landau; Jeremy Steele; James Spicer
Journal:  J Thorac Cardiovasc Surg       Date:  2014-10-14       Impact factor: 5.209
View more
  1 in total

1.  Aurora Kinase A as a Diagnostic and Prognostic Marker of Malignant Mesothelioma.

Authors:  Zhenying Guo; Li Shen; Ningning Li; Xiaoxiao Wu; Canming Wang; Zheng Gu; Zhongjian Chen; Junping Liu; Weimin Mao; Yuchen Han
Journal:  Front Oncol       Date:  2021-12-08       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.